Natixis Advisors LLC Decreases Stake in HCA Healthcare, Inc. $HCA

Natixis Advisors LLC lessened its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 121,250 shares of the company’s stock after selling 3,257 shares during the quarter. Natixis Advisors LLC owned about 0.05% of HCA Healthcare worth $56,607,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. 3Chopt Investment Partners LLC increased its position in HCA Healthcare by 5.4% in the fourth quarter. 3Chopt Investment Partners LLC now owns 1,098 shares of the company’s stock worth $513,000 after purchasing an additional 56 shares during the last quarter. Crestmont Private Wealth LLC bought a new stake in HCA Healthcare in the fourth quarter worth $201,000. Root Financial Partners LLC increased its position in HCA Healthcare by 6.2% in the fourth quarter. Root Financial Partners LLC now owns 444 shares of the company’s stock worth $207,000 after purchasing an additional 26 shares during the last quarter. BNP Paribas increased its position in HCA Healthcare by 5.4% in the fourth quarter. BNP Paribas now owns 2,469 shares of the company’s stock worth $1,154,000 after purchasing an additional 126 shares during the last quarter. Finally, Ellevest Inc. increased its position in HCA Healthcare by 11.1% in the fourth quarter. Ellevest Inc. now owns 531 shares of the company’s stock worth $248,000 after purchasing an additional 53 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Stephens cut their price objective on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Oppenheimer cut their price objective on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Mizuho boosted their price objective on shares of HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research report on Wednesday, February 25th. Truist Financial cut their price objective on shares of HCA Healthcare from $546.00 to $535.00 and set a “buy” rating on the stock in a research report on Monday, April 27th. Finally, UBS Group boosted their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research report on Monday, February 23rd. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $515.77.

HCA Healthcare Trading Down 0.9%

NYSE HCA opened at $364.00 on Thursday. The company’s 50-day moving average price is $444.21 and its 200-day moving average price is $478.72. The stock has a market cap of $80.75 billion, a PE ratio of 12.52, a PEG ratio of 1.16 and a beta of 1.12. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same period in the previous year, the company posted $6.45 EPS. HCA Healthcare’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.